Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -5.46%235B | -5.76%1.09T | -5.46%773.81B | -5.88%512.5B | -6.21%248.56B | -8.16%1.16T | -7.30%818.48B | -7.83%544.52B | -2.56%265.01B | 9.45%1.26T |
| Special items of operating revenue | -0.97%712.04M | ---- | 24.47%2.25B | ---- | 13.38%719.03M | ---- | 12.54%1.8B | ---- | -2.56%634.19M | ---- |
| Operating income | -5.45%235.71B | -5.76%1.09T | -5.39%776.06B | -5.88%512.5B | -6.16%249.28B | -8.16%1.16T | -7.26%820.28B | -7.83%544.52B | -2.56%265.65B | 9.45%1.26T |
| Cost of sales | ---- | 5.19%-995.54B | ---- | 5.56%-470.08B | ---- | 7.95%-1.05T | ---- | 7.80%-497.77B | ---- | -9.11%-1.14T |
| Operating expenses | 4.91%-216.37B | 5.19%-995.54B | 5.30%-706.95B | 5.56%-470.08B | 6.08%-227.54B | 7.95%-1.05T | 7.00%-746.49B | 7.80%-497.77B | 2.21%-242.26B | -9.11%-1.14T |
| Special items of gross profit | 0.97%-712.04M | ---- | -24.47%-2.25B | ---- | -13.38%-719.03M | ---- | -12.54%-1.8B | ---- | 2.56%-634.19M | ---- |
| Gross profit | -11.38%18.63B | -11.13%97.96B | -7.12%66.86B | -9.28%42.42B | -7.59%21.02B | -10.15%110.23B | -10.29%71.99B | -8.15%46.76B | -6.12%22.75B | 12.67%122.69B |
| Selling expenses | -0.40%-1.41B | 7.78%-6.4B | 1.68%-4.31B | 1.96%-2.85B | -4.34%-1.41B | -1.37%-6.94B | 0.81%-4.38B | 5.15%-2.91B | 10.82%-1.35B | -8.25%-6.85B |
| Administrative expenses | 11.77%-5.2B | 9.11%-23.17B | 13.78%-15.2B | 13.25%-11.19B | 12.11%-5.9B | 11.96%-25.5B | 6.53%-17.63B | 1.72%-12.9B | -4.18%-6.71B | -9.64%-28.96B |
| Research and development expenses | 12.43%-2.76B | 15.73%-22.44B | 15.01%-13.67B | 12.09%-8.11B | 9.17%-3.15B | 11.23%-26.63B | 9.68%-16.09B | 10.36%-9.23B | 9.64%-3.47B | -8.14%-30B |
| Profit from asset sales | 34.80%-17.46M | ---- | -14.40%72.03M | ---- | -117.92%-26.78M | ---- | -63.76%84.15M | ---- | -40.01%149.42M | ---- |
| Revaluation surplus | 2,043.32%53.73M | ---- | -554.43%-280M | ---- | 102.96%2.51M | ---- | 118.59%61.62M | ---- | -83.41%-84.69M | ---- |
| -Changes in the fair value of other assets | 2,043.32%53.73M | ---- | -554.43%-280M | ---- | 102.96%2.51M | ---- | 118.59%61.62M | ---- | -83.41%-84.69M | ---- |
| Impairment and provision | 18.85%-588.47M | 5.43%-6.43B | -19.93%-3.51B | -18.05%-2.07B | -9.02%-725.18M | 4.88%-6.8B | -25.00%-2.92B | 5.34%-1.76B | 39.87%-665.18M | -113.79%-7.15B |
| -Other impairment is provision | 18.85%-588.47M | 5.43%-6.43B | -19.93%-3.51B | -18.05%-2.07B | -9.02%-725.18M | 4.88%-6.8B | -25.00%-2.92B | 5.34%-1.76B | 39.87%-665.18M | -113.79%-7.15B |
| Operating interest expense | 27.73%-197.02M | ---- | -31.16%-466.96M | ---- | -50.37%-272.61M | ---- | -18.74%-356.03M | ---- | -29.89%-181.29M | ---- |
| Special items of operating profit | 11.20%1.43B | 66.39%-410M | -0.73%3B | 133.04%186M | -12.82%1.29B | 52.34%-1.22B | 1.59%3.02B | -718.68%-563M | -17.24%1.48B | -101.42%-2.56B |
| Operating profit | -9.28%8.72B | -9.37%39.1B | -4.40%29.01B | -5.27%18.38B | -11.23%9.62B | -8.54%43.14B | -13.96%30.34B | -14.36%19.4B | -8.82%10.83B | 7.71%47.17B |
| Financing income | 10.05%1.77B | -18.54%6.42B | -20.93%4.82B | -19.61%3.58B | -24.94%1.61B | -9.61%7.88B | -6.11%6.1B | 3.35%4.45B | 10.67%2.15B | 21.34%8.71B |
| Financing cost | -5.36%-3.17B | -10.00%-14.1B | -6.53%-9.78B | -13.25%-6.5B | -3.73%-3.01B | -7.74%-12.81B | -0.90%-9.18B | -3.65%-5.74B | -11.95%-2.9B | -24.17%-11.89B |
| Share of profits of associates | ---- | 4.59%3.28B | ---- | -11.12%1.48B | ---- | -32.83%3.13B | ---- | -23.96%1.66B | ---- | -1.44%4.67B |
| Share of profit from joint venture company | ---- | 66.30%-244M | ---- | 48.13%-111M | ---- | 32.65%-724M | ---- | 66.46%-214M | ---- | 25.19%-1.08B |
| Special items of earning before tax | -116.20%-32.1M | ---- | 240.29%712.97M | ---- | 287.63%198.19M | ---- | 1,116.78%209.52M | ---- | 128.49%51.13M | ---- |
| Earning before tax | -19.64%6.47B | -15.17%34.45B | -12.83%23.73B | -13.99%16.82B | -18.38%8.05B | -14.64%40.61B | -14.95%27.23B | -14.85%19.56B | -8.47%9.86B | 6.46%47.58B |
| Tax | ---- | 17.77%-8.1B | ---- | 5.40%-3.68B | ---- | 0.90%-9.86B | ---- | 17.35%-3.89B | ---- | -2.25%-9.94B |
| After-tax profit from continuing operations | -25.20%4.91B | -14.34%26.35B | -14.44%19.22B | -16.13%13.14B | -18.29%6.56B | -18.28%30.76B | -14.66%22.46B | -14.21%15.67B | -9.47%8.03B | 7.64%37.64B |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Earning after tax | -25.20%4.91B | -14.34%26.35B | -14.44%19.22B | -16.13%13.14B | -18.29%6.56B | -18.28%30.76B | -14.66%22.46B | -14.21%15.67B | -9.47%8.03B | 7.64%37.64B |
| Minority profit | 2.55%547.57M | 20.34%3.46B | -8.62%1.73B | -5.40%1.32B | -2.18%533.95M | -30.89%2.87B | -18.07%1.89B | -31.36%1.39B | -44.75%545.85M | 12.45%4.15B |
| Adjustment items of profit attributable to shareholders | ---- | ---- | ---2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -27.65%4.36B | -17.91%22.89B | -14.97%17.49B | -17.17%11.83B | -19.46%6.03B | -16.71%27.89B | -14.33%20.57B | -12.07%14.28B | -5.04%7.48B | 7.07%33.48B |
| Basic earnings per share | -27.76%0.177 | -21.84%0.848 | -18.11%0.642 | -22.56%0.412 | -15.22%0.245 | -16.15%1.085 | -14.13%0.784 | -12.07%0.532 | -5.25%0.289 | 8.01%1.294 |
| Diluted earnings per share | -27.76%0.177 | -21.77%0.848 | -18.11%0.642 | -22.56%0.412 | -15.22%0.245 | -16.10%1.084 | -14.13%0.784 | -12.07%0.532 | -5.25%0.289 | 7.85%1.292 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Limited, Deloitte China CPA Firm (Special General Partnership) | -- | -- | -- | PwC, PwC Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.